These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16612424)

  • 1. Debate on the paper by David Vlahov & David D. Celentano.
    Kalichman A
    Cad Saude Publica; 2006 Apr; 22(4):727-8; author reply 730-1. PubMed ID: 16612424
    [No Abstract]   [Full Text] [Related]  

  • 2. Debate on the paper by David Vlahov & David D. Celentano. HIV infection, injection drug users and bioethics.
    Palácios M
    Cad Saude Publica; 2006 Apr; 22(4):725-6; author reply 730-1. PubMed ID: 16612423
    [No Abstract]   [Full Text] [Related]  

  • 3. Debate on the paper by David Vlahov & David D. Celentano.
    Vargas EV
    Cad Saude Publica; 2006 Apr; 22(4):722-3; author reply 730-1. PubMed ID: 16612420
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate on the paper by David Vlahov & David D. Celentano. The double dimension of care and management of injecting drug users living with HIV/AIDS.
    Bastos FI; Boily MC
    Cad Saude Publica; 2006 Apr; 22(4):719-20; author reply 730-1. PubMed ID: 16612418
    [No Abstract]   [Full Text] [Related]  

  • 5. Debate on the paper by David Vlahov & David D. Celentano. Drug users and the HIV/AIDS epidemic: old problems, new perspectives.
    Monteiro S
    Cad Saude Publica; 2006 Apr; 22(4):724-5; author reply 730-1. PubMed ID: 16612422
    [No Abstract]   [Full Text] [Related]  

  • 6. Debate on the paper by David Vlahov & David D. Celentano. The question of technology transfer: how does that apply to Brazilian reality?
    Pechansky F
    Cad Saude Publica; 2006 Apr; 22(4):720-1; author reply 730-1. PubMed ID: 16612419
    [No Abstract]   [Full Text] [Related]  

  • 7. Debate on the paper by David Vlahov & David D. Celentano. Access to AIDS treatment: appropriateness and correctness in the pursuit of good practice.
    Ayres JR
    Cad Saude Publica; 2006 Apr; 22(4):728-30; author reply 730-1. PubMed ID: 16612425
    [No Abstract]   [Full Text] [Related]  

  • 8. Debate on the paper by David Vlahov & David D. Celentano.
    de Lima DB
    Cad Saude Publica; 2006 Apr; 22(4):723; author reply 730-1. PubMed ID: 16612421
    [No Abstract]   [Full Text] [Related]  

  • 9. Access to antiretroviral therapy in HIV-infected injection drug users.
    Antela A
    AIDS; 2001 Sep; 15(13):1727-8. PubMed ID: 11546949
    [No Abstract]   [Full Text] [Related]  

  • 10. Mortality among urban drug users and the impact of highly active antiretroviral therapy.
    Celentano DD
    Clin Infect Dis; 2005 Sep; 41(6):873-4. PubMed ID: 16107988
    [No Abstract]   [Full Text] [Related]  

  • 11. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia.
    Wisaksana R; Indrati AK; Fibriani A; Rogayah E; Sudjana P; Djajakusumah TS; Sumantri R; Alisjahbana B; van der Ven A; van Crevel R
    Addiction; 2010 Jun; 105(6):1055-61. PubMed ID: 20331555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is antiretroviral therapy modifying the HIV epidemic?
    Grulich AE; Wilson DP
    Lancet; 2010 Nov; 376(9755):1824; author reply 1825. PubMed ID: 21111902
    [No Abstract]   [Full Text] [Related]  

  • 14. What's new for injection drug users with HIV infection?
    Clarke SM; Mulcahy FM
    Sex Transm Infect; 2003 Apr; 79(2):80-3. PubMed ID: 12690121
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
    Lert F; Kazatchkine MD
    Int J Drug Policy; 2007 Aug; 18(4):255-61. PubMed ID: 17689373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention. HAART expansion leads to drop in new infections among infection drug users.
    AIDS Policy Law; 2010 Mar; 25(4):1. PubMed ID: 20480629
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV infection in IVDUs decreases with expanded HIV treatment coverage.
    AIDS Patient Care STDS; 2010 Apr; 24(4):266. PubMed ID: 20405530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Health services utilization according to gender in a cohort of intravenous drug users infected with HIV].
    García de la Hera M; Ruiz I; Pérez-Hoyos S; Hernández Aguado I
    Med Clin (Barc); 2003 Apr; 120(13):489-93. PubMed ID: 12716541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV treatment, injection drug use, and illicit drug policies.
    Wood E; Kerr T; Montaner JS
    Lancet; 2007 Jul; 370(9581):8-10. PubMed ID: 17617253
    [No Abstract]   [Full Text] [Related]  

  • 20. Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death.
    Vlahov D; Celentano DD
    Cad Saude Publica; 2006 Apr; 22(4):705-18. PubMed ID: 16612417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.